Latest Insider Transactions at Emergent Bio Solutions Inc. (EBS)
This section provides a real-time view of insider transactions for Emergent Bio Solutions Inc. (EBS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Emergent BioSolutions Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Emergent BioSolutions Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 10
2020
|
Fuad El Hibri Director |
SELL
Open market or private sale
|
Direct |
19,391
-1.7%
|
$1,706,408
$88.21 P/Share
|
|
Nov 10
2020
|
Fuad El Hibri Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,391
+1.67%
|
$504,166
$26.45 P/Share
|
|
Nov 09
2020
|
Fuad El Hibri Director |
SELL
Open market or private sale
|
Direct |
20,000
-1.75%
|
$1,900,000
$95.26 P/Share
|
|
Nov 09
2020
|
Fuad El Hibri Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+1.72%
|
$520,000
$26.45 P/Share
|
|
Nov 03
2020
|
Fuad El Hibri Director |
SELL
Open market or private sale
|
Direct |
20,000
-1.75%
|
$1,800,000
$90.74 P/Share
|
|
Nov 03
2020
|
Fuad El Hibri Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+1.72%
|
$520,000
$26.45 P/Share
|
|
Nov 02
2020
|
Fuad El Hibri Director |
SELL
Open market or private sale
|
Direct |
20,000
-1.75%
|
$1,800,000
$90.44 P/Share
|
|
Nov 02
2020
|
Fuad El Hibri Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+1.72%
|
$520,000
$26.45 P/Share
|
|
Oct 01
2020
|
Marvin L White Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,629
+50.0%
|
-
|